Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03811275 · ClinicalTrials.gov registry record · NA
Task or Virtual Reality Intervention for Improving UE Function
A NA study, sponsored by Idaho State University.
- Terminated
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT03811275: Clinical Trial NA study, sponsored by Idaho State University.
NCT03811275 is a NA study that was terminated before completion, run by Idaho State University. The registered enrollment target is 5 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03811275, a NA study, was terminated before completion, sponsored by Idaho State University.
- TERMINATED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
People with one arm that does not function well due to a stroke, head injury, or cerebral palsy, and a fully functional other arm, will be randomly assigned to receive one of the two interventions first, followed by the other intervention. The two interventions include a task-based intervention and a virtual reality intervention that provides a reflected image of the involved arm. The task-based intervention will consist of setting up activities of interest to be done using the involved arm and structuring practice and meaningful feedback to assist learning. The virtual reality intervention will consist of the person wearing the virtual reality device and practicing virtual tasks using the intact arm while seeing the involved arm. Intervention sessions will last approximately 30 minutes and will be held 3 times/week for 3 weeks each for a total of 9 sessions for each intervention. Testing of the involved arm's function will be done before the interventions, after receiving 9 sessions of each intervention, and one month after completing the second intervention received.
Primary Outcome
Performance-based measure of arm impairment post stroke; a positive change in score indicates improvement
Interventions
- BEHAVIORAL Virtual Reality (A) then Task (B)
- BEHAVIORAL Task (B) then Virtual Reality (A)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2018-09-08 |
| Est. Completion | 2024-04-26 |
| Phase | NA |
Why NCT03811275 stopped before completion
NCT03811275 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Virtual Reality (A) then Task (B) is the first listed.
NCT03811275 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03811275 about?
NCT03811275 is a clinical study titled "Task or Virtual Reality Intervention for Improving UE Function". People with one arm that does not function well due to a stroke, head injury, or cerebral palsy, and a fully functional other arm, will be randomly assigned to receive one of the two interventions first, followed by the other intervention. The two interventions include a task-based intervention and ...
What is the current status of trial NCT03811275?
This trial is currently terminated. It is a NA study. The enrollment target is 5 participants. The study started on 2018-09-08. Estimated completion is 2024-04-26.
What interventions are being tested in trial NCT03811275?
The interventions under investigation include: Virtual Reality (A) then Task (B) (BEHAVIORAL), Task (B) then Virtual Reality (A) (BEHAVIORAL).
Who is sponsoring clinical trial NCT03811275?
This trial is sponsored by Idaho State University, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03811275's enrollment target sits among peer trials
5 1988th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI